- Home
- LVRO vs RCKT Comparison
LVRO vs RCKT Comparison
Compare LVRO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- RCKT
- Stock Information
- Founded
- LVRO 2017
- RCKT 1999
- Country
- LVRO Brazil
- RCKT United States
- Employees
- LVRO N/A
- RCKT N/A
- Industry
- LVRO Blank Checks
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- LVRO Finance
- RCKT Health Care
- Exchange
- LVRO Nasdaq
- RCKT Nasdaq
- Market Cap
- LVRO 279.6M
- RCKT 326.4M
- IPO Year
- LVRO N/A
- RCKT N/A
- Fundamental
- Price
- LVRO $2.24
- RCKT $2.95
- Analyst Decision
- LVRO Sell
- RCKT Buy
- Analyst Count
- LVRO 3
- RCKT 13
- Target Price
- LVRO $1.88
- RCKT $18.50
- AVG Volume (30 Days)
- LVRO 8.8K
- RCKT 4.3M
- Earning Date
- LVRO 07-11-2025
- RCKT 08-04-2025
- Dividend Yield
- LVRO N/A
- RCKT N/A
- EPS Growth
- LVRO N/A
- RCKT N/A
- EPS
- LVRO N/A
- RCKT N/A
- Revenue
- LVRO $1,667,345,189.00
- RCKT N/A
- Revenue This Year
- LVRO N/A
- RCKT N/A
- Revenue Next Year
- LVRO $12.46
- RCKT N/A
- P/E Ratio
- LVRO N/A
- RCKT N/A
- Revenue Growth
- LVRO N/A
- RCKT N/A
- 52 Week Low
- LVRO $1.90
- RCKT $2.19
- 52 Week High
- LVRO $5.69
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- LVRO 43.94
- RCKT 41.69
- Support Level
- LVRO $1.95
- RCKT $2.40
- Resistance Level
- LVRO $2.22
- RCKT $2.70
- Average True Range (ATR)
- LVRO 0.20
- RCKT 0.21
- MACD
- LVRO -0.01
- RCKT 0.15
- Stochastic Oscillator
- LVRO 31.25
- RCKT 73.53
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.